We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Ra Pharmaceuticals Inc | NASDAQ:RARX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 47.995 | 40.00 | 50.00 | 0 | 01:00:00 |
Ra Pharmaceuticals, Inc. (NASDAQ:RARX), a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for the treatment of complement-mediated diseases, today announced that Doug Treco, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the BMO Capital Markets Prescriptions for Success Healthcare Conference on Thursday, December 14, 2017 at 3:30 p.m. E.T. The conference is being held at the Westin New York Grand Central Hotel.
A live webcast of the presentation can be accessed by visiting the investor relations section of the Company’s website, www.rapharma.com. A replay of the presentation will also be available and archived on the site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical company focusing on the development of next-generation therapeutics for complement-mediated diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171207005396/en/
Ra Pharmaceuticals, Inc.Investors:Jennifer Robinson, 617-674-9873jrobinson@rapharma.comorMedia:Argot PartnersEliza Schleifstein, 917-763-8106eliza@argotpartners.com
1 Year Ra Pharmaceuticals Chart |
1 Month Ra Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions